title: Italian risk-sharing agreements on drugs: are they worthwhile?
authors.affiliation: CESAV, Centre for Health Economics, IRCCS Institute for Pharmacological Research 'Mario Negri', Via Camozzi, 3 c/o Villa Camozzi, Ranica, 24020, Bergamo, Italy, livio.garattini@marionegri.it.
authors.forename: Livio
authors.initials: L
authors.lastname: Garattini
authors.forename: Alessandro
authors.initials: A
authors.lastname: Curto
authors.forename: Katelijne
authors.initials: K
authors.lastname: van de Vooren
mesh_terms: D003363:Cost Control; D016527:Drug Costs; D004345:Drug Industry / Q000191:economics / Q000458:organization & administration*; D006801:Humans; D007558:Italy; D020414:Risk Sharing, Financial / Q000191:economics / Q000458:organization & administration*
references.citation: Pharmacoeconomics. 2010;28(2):93-102
references.pmid: 20085386
references.citation: Int J Technol Assess Health Care. 2011 Apr;27(2):169-72
references.pmid: 21429288
references.citation: Value Health. 2013 Jul-Aug;16(5):703-19
references.pmid: 23947963